Oct 16 (Reuters) - Teva Pharmaceutical Industries Ltd:
* Teva comments on Mylan paragraph IV filing for Copaxone; files
lawsuit against generic filer for patent infringement
* Comments on Mylan Paragraph IV filing for Copaxone; files lawsuit against
generic filer for patent infringement
* Says filed a lawsuit against Mylan pharmaceuticals, Mylan Inc and Natco
Pharma Ltd for patent infringement
* Says remains committed to vigorously defending its Copaxone intellectual
property rights against infringement
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Teva comments on Mylan paragraph IV filing for Copaxone; files
lawsuit against generic filer for patent infringement
* Comments on Mylan Paragraph IV filing for Copaxone; files lawsuit against
generic filer for patent infringement
* Says filed a lawsuit against Mylan pharmaceuticals, Mylan Inc and Natco
Pharma Ltd for patent infringement
* Says remains committed to vigorously defending its Copaxone intellectual
property rights against infringement
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.